Skip to main content

Table 3 Diagnostic accuracy of MTV and ASP towards IR (stages)

From: Pretherapeutic FDG-PET total metabolic tumor volume predicts response to induction therapy in pediatric Hodgkin’s lymphoma

 

Stage I/II

Stage III/IV

Parameter

Sens. (95%-CI)

Spec. (95%-CI)

Sens. (95%-CI)

Spec. (95%-CI)

NPV (95%-CI)

PPV (95%-CI)

NPV (95%-CI)

PPV (95%-CI)

MTV

94% (70 to 100%)

64% (31 to 89%)

75% (43 to 95%)

91% (59 to 100%)

88% (47 to 100%)

79% (54 to 94%)

77% (46 to 95%)

90% (55 to 100%)

ASP

81% (54 to 96%)

55% (23 to 83%)

83% (52 to 98%)

64% (31 to 89%)

67% (30 to 93%)

72% (47 to 90%)

78% (40 to 97%)

71% (42 to 92%)

  1. Sens. sensitivity, 95%-CI 95%-confidence interval, spec. Specificity, NPV negative predictive value, PPV positive predictive value, MTV metabolic tumor volume, ASP asphericity